Litcius/Paper detail

β-Glucuronidase-Activated Bioluminescence Probe for <i>In Vivo</i> Tumor Imaging

Liang Yang, Xianbao Sun, Lingling Xu, Xiaotong Cheng, Xiaoyang Liu, Yu Deng, Xinyi Hu, Gaolin Liang

2023Analytical Chemistry18 citationsDOI

Abstract

β-Glucuronidase (GLU) is a hallmark enzyme for many malignant tumors, but bioluminescence (BL) probes that enable GLU imaging in vivo have not been reported. Herein, we rationally designed the BL probe Glc-Luc to address this issue. In vitro results demonstrated the specific responsiveness of Glc-Luc toward GLU with a calculated catalytic efficiency ( k cat / K m ) of 0.0109 μM –1 min –1 and a limit of detection (LOD) of 1.39 U/mL. Moreover, Glc-Luc rendered 3.1-fold and 15.9-fold higher BL intensities over the control groups in cell lysates and tumor-bearing mice, respectively. We anticipate that Glc-Luc could be further applied for the sensitive diagnosis of GLU-related diseases.

Topics & Concepts

ChemistryBioluminescenceIn vivoBioluminescence imagingEnzyme kineticsDetection limitEnzymeMolecular biologyEx vivoIn vitroBiochemistryLuciferaseChromatographyActive siteTransfectionBiologyBiotechnologyGenebioluminescence and chemiluminescence researchAdvanced biosensing and bioanalysis techniquesNanoplatforms for cancer theranostics
β-Glucuronidase-Activated Bioluminescence Probe for <i>In Vivo</i> Tumor Imaging | Litcius